| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 30 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 30 |
| 2 | CARBOPLATIN | 16 |
| 3 | RITUXIMAB | 15 |
| 4 | TACROLIMUS | 15 |
| 5 | PREDNISONE | 14 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 7 | TACROLIMUS OINTMENT 0.1% | 14 |
| 8 | METHOTREXATE SODIUM | 12 |
| 9 | CYCLOPHOSPHAMIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARMUSTINE | 6 | 0.0013 |
| 1 | DACARBAZINE | 5 | 0.0007 |
| 2 | TESAMORELIN | 1 | 0.0006 |
| 3 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 4 | BLEOMYCIN SULFATE | 6 | 0.0006 |
| 5 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 3 | 0.0004 |
| 7 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| 8 | BUSPIRONE HYDROCHLORIDE | 3 | 0.0003 |
| 9 | ATOVAQUONE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 36 |
| 1 | Alkylating Drug [EPC] | 17 |
| 2 | Platinum-based Drug [EPC] | 17 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 15 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| 5 | Purine Antimetabolite [EPC] | 11 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 7 | Benzodiazepine [EPC] | 9 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 9 | Thalidomide Analog [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 1 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 2 | Antimalarial [EPC] | 2 | 0.0002 |
| 3 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Phenothiazine [EPC] | 4 | 0.0001 |
| 7 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 2 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 9 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |